Stocks To Buy: Nuvama sees 40% upside for this IT BPO healthcare service provider

Sagility, a key player in the healthcare IT services sector, has been highlighted by Nuvama as a potential investment opportunity. The firm projects that Sagility's revenue, measured in US dollars, will grow at a compounded annual growth rate (CAGR) of 13% between financial years 2026 and 2029. This growth is expected to be supported by a healthy expansion in its adjusted earnings per share (EPS), which could grow at a CAGR of 19% over the same period. Additionally, the company is forecast to maintain robust EBITDA margins between 24% and 25%.
For investors, this outlook suggests a strong potential for capital appreciation, with the stock offering a possible upside of 40%. The growth in dollar-denominated revenue indicates a successful strategy for capturing international markets, while the high margin profile points to efficient operations. This makes Sagility an interesting case study for investors looking at the IT-BPO space.
Investors should monitor the company's ability to sustain these growth rates and margin levels amidst competitive market conditions. Key factors to watch include its client acquisition in the US healthcare sector and its execution on expansion plans. The company's performance in the coming quarters will be critical in validating these long-term projections.
Affected stocks
Bullish1 stockBull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.
Key takeaways
- Concerns Sagility (SAGILITY).
- Category: Sector.
- AI reads the tone as positive (potentially bullish) for the stock.
- Assessed as a significant, market-relevant update.
Why it matters
A meaningful update for Sagility worth tracking. The tone is positive — historically associated with upward pressure, though not predictive. Use the price and stock snapshot to gauge how the market is responding.

















